These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 32741859)
21. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Takeuchi H; Yamamoto H; Niwa T; Hino T; Kawashima Y Pharm Res; 1996 Jun; 13(6):896-901. PubMed ID: 8792429 [TBL] [Abstract][Full Text] [Related]
22. Presence of electrostatically adsorbed polysaccharides improves spray drying of liposomes. Karadag A; Özçelik B; Sramek M; Gibis M; Kohlus R; Weiss J J Food Sci; 2013 Feb; 78(2):E206-21. PubMed ID: 23324113 [TBL] [Abstract][Full Text] [Related]
23. Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin. Guggi D; Krauland AH; Bernkop-Schnürch A J Control Release; 2003 Sep; 92(1-2):125-35. PubMed ID: 14499191 [TBL] [Abstract][Full Text] [Related]
24. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Qiang F; Shin HJ; Lee BJ; Han HK Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082 [TBL] [Abstract][Full Text] [Related]
25. Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery. Reis CP; Ribeiro AJ; Veiga F; Neufeld RJ; Damgé C Drug Deliv; 2008 Feb; 15(2):127-39. PubMed ID: 18293199 [TBL] [Abstract][Full Text] [Related]
26. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. Bi R; Shao W; Wang Q; Zhang N J Drug Target; 2008 Nov; 16(9):639-48. PubMed ID: 18982512 [TBL] [Abstract][Full Text] [Related]
27. Mucoadhesive microparticles for local treatment of gastrointestinal diseases. Preisig D; Roth R; Tognola S; Varum FJ; Bravo R; Cetinkaya Y; Huwyler J; Puchkov M Eur J Pharm Biopharm; 2016 Aug; 105():156-65. PubMed ID: 27302556 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging. Tahara K; Nishio M; Takeuchi H Drug Dev Ind Pharm; 2018 Apr; 44(4):608-614. PubMed ID: 29166794 [TBL] [Abstract][Full Text] [Related]
29. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment. Mehanna MM; Elmaradny HA; Samaha MW Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004 [TBL] [Abstract][Full Text] [Related]
30. Preparation and Evaluation of Enteric-Coated Chitosan Derivative-Based Microparticles Loaded with Salmon Calcitonin as an Oral Delivery System. Onishi H; Tokuyasu A Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649146 [TBL] [Abstract][Full Text] [Related]
31. Preparation of chitosan-coated liposomes as a novel carrier system for the antiviral drug Triazavirin. Kozhikhova KV; Ivantsova MN; Tokareva MI; Shulepov ID; Tretiyakov AV; Shaidarov LV; Rusinov VL; Mironov MA Pharm Dev Technol; 2018 Apr; 23(4):334-342. PubMed ID: 27681534 [TBL] [Abstract][Full Text] [Related]
32. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10. Shao Y; Yang L; Han HK Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680 [TBL] [Abstract][Full Text] [Related]
33. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization. Manconi M; Mura S; Manca ML; Fadda AM; Dolz M; Hernandez MJ; Casanovas A; Díez-Sales O Int J Pharm; 2010 Jun; 392(1-2):92-100. PubMed ID: 20338230 [TBL] [Abstract][Full Text] [Related]
34. Preparation of novel capsosome with liposomal core by layer-by-Layer self-assembly of sodium hyaluronate and chitosan. Yoo CY; Seong JS; Park SN Colloids Surf B Biointerfaces; 2016 Aug; 144():99-107. PubMed ID: 27085041 [TBL] [Abstract][Full Text] [Related]
35. Chitosan-coated liposomes for delivery to lungs by nebulisation. Zaru M; Manca ML; Fadda AM; Antimisiaris SG Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583 [TBL] [Abstract][Full Text] [Related]
36. Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy. Andersen T; Bleher S; Eide Flaten G; Tho I; Mattsson S; Škalko-Basnet N Mar Drugs; 2015 Jan; 13(1):222-36. PubMed ID: 25574737 [TBL] [Abstract][Full Text] [Related]
37. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Han HK; Shin HJ; Ha DH Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117 [TBL] [Abstract][Full Text] [Related]
38. Chitosan: a unique polysaccharide for drug delivery. Felt O; Buri P; Gurny R Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553 [TBL] [Abstract][Full Text] [Related]
39. Polymer coated liposomes for use in the oral cavity - a study of the in vitro toxicity, effect on cell permeability and interaction with mucin. Klemetsrud T; Kjøniksen AL; Hiorth M; Jacobsen J; Smistad G J Liposome Res; 2018 Mar; 28(1):62-73. PubMed ID: 27809639 [TBL] [Abstract][Full Text] [Related]
40. Chitosan-reduced gold nanoparticles: a novel carrier for the preparation of spray-dried liposomes for topical delivery. Padamwar MN; Patole MS; Pokharkar VB J Liposome Res; 2011 Dec; 21(4):324-32. PubMed ID: 21623705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]